Adaptimmune Therapeutics Plc (ADAP)

Market is closed

Insider Trading: Sales

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Behbahani	$0.01	14,671,794	$176,061.53	0	2025-08-18	Filing
Behbahani	$0.01	4,828,206	$53,110.27	14,671,794	2025-08-15	Filing
Ecor1 Large Shareholder	$0.10	27,433,338	$2,800,943.81	100,371,882	2025-07-30	Filing
Ecor1 Large Shareholder	$0.10	2,687,460	$271,970.95	127,805,220	2025-07-29	Filing
Ecor1 Large Shareholder	$0.11	33,931,740	$3,817,320.75	130,492,680	2025-07-28	Filing
Norry Officer	$0.58	5,584	$3,243.19	7,510	2025-01-17	Filing
Lunger Officer	$0.58	5,584	$3,243.19	7,510	2025-01-17	Filing
Bertrand Officer	$0.58	5,584	$3,243.19	7,510	2025-01-17	Filing
Rawcliffe Officer, Director	$0.58	30,601	$17,773.06	44,327	2025-01-17	Filing
Rawcliffe Officer, Director	$0.57	29,096	$16,724.38	41,582	2025-01-15	Filing
Rawcliffe Officer, Director	$0.59	17,934	$10,543.40	25,711	2025-01-13	Filing
Rawcliffe Officer, Director	$0.59	12,539	$7,371.68	17,801	2025-01-13	Filing
Piccina Officer	$0.57	12,991	$7,467.23	18,421	2025-01-15	Filing
Norry Officer	$0.57	9,803	$5,634.76	13,756	2025-01-15	Filing
Norry Officer	$0.59	8,124	$4,776.10	11,516	2025-01-13	Filing
Norry Officer	$0.59	4,268	$2,509.16	5,845	2025-01-13	Filing
Lunger Officer	$0.57	9,803	$5,634.76	13,756	2025-01-15	Filing
Lunger Officer	$0.59	5,471	$3,216.40	7,623	2025-01-13	Filing
Lunger Officer	$0.59	4,268	$2,509.16	5,845	2025-01-13	Filing
Bertrand Officer	$0.57	9,803	$5,634.76	13,756	2025-01-15	Filing